Abeona Therapeutics (ABEO) Current Leases (2019 - 2026)

Abeona Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• On a quarterly basis, Current Leases rose 107.5% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 107.5% increase from a year earlier, with the FY2025 full-year figure at $864000.0, up 4.98% from the prior year.
• Current Leases climbed to $1.3 million in Q1 2026 per ABEO's latest filing, from $864000.0 in the prior quarter.
• Across five years, Current Leases topped out at $1.8 million in Q1 2022 and bottomed at $102000.0 in Q3 2025.
• The 5-year median for Current Leases is $1.3 million (2026), against an average of $1.3 million.
• Across the five-year window, Current Leases slumped 90.35% in 2025 and jumped 107.5% in 2026, its largest moves.
• Year by year, Current Leases stood at $1.8 million in 2022, then sank by 43.71% to $998000.0 in 2023, then decreased by 17.54% to $823000.0 in 2024, then grew by 4.98% to $864000.0 in 2025, then soared by 47.22% to $1.3 million in 2026.
• Per Business Quant, the three latest ABEO Current Leases figures stand at $1.3 million (Q1 2026), $864000.0 (Q4 2025), and $102000.0 (Q3 2025).